66 related articles for article (PubMed ID: 21767644)
1. Olfactory neuron-specific expression of A30P α-synuclein exacerbates dopamine deficiency and hyperactivity in a novel conditional model of early Parkinson's disease stages.
Nuber S; Petrasch-Parwez E; Arias-Carrión O; Koch L; Kohl Z; Schneider J; Calaminus C; Dermietzel R; Samarina A; Boy J; Nguyen HP; Teismann P; Velavan TP; Kahle PJ; von Hörsten S; Fendt M; Krüger R; Riess O
Neurobiol Dis; 2011 Nov; 44(2):192-204. PubMed ID: 21767644
[TBL] [Abstract][Full Text] [Related]
2. Glial A30P alpha-synuclein pathology segregates neurogenesis from anxiety-related behavior in conditional transgenic mice.
Marxreiter F; Ettle B; May VE; Esmer H; Patrick C; Kragh CL; Klucken J; Winner B; Riess O; Winkler J; Masliah E; Nuber S
Neurobiol Dis; 2013 Nov; 59():38-51. PubMed ID: 23867236
[TBL] [Abstract][Full Text] [Related]
3. The A30P α-synuclein mutation decreases subventricular zone proliferation.
Zhang XM; Anwar S; Kim Y; Brown J; Comte I; Cai H; Cai NN; Wade-Martins R; Szele FG
Hum Mol Genet; 2019 Jul; 28(14):2283-2294. PubMed ID: 31267130
[TBL] [Abstract][Full Text] [Related]
4. A30P α-Synuclein interferes with the stable integration of adult-born neurons into the olfactory network.
Neuner J; Filser S; Michalakis S; Biel M; Herms J
Sci Rep; 2014 Feb; 4():3931. PubMed ID: 24488133
[TBL] [Abstract][Full Text] [Related]
5. α-synuclein inclusions are abundant in non-neuronal cells in the anterior olfactory nucleus of the Parkinson's disease olfactory bulb.
Stevenson TJ; Murray HC; Turner C; Faull RLM; Dieriks BV; Curtis MA
Sci Rep; 2020 Apr; 10(1):6682. PubMed ID: 32317654
[TBL] [Abstract][Full Text] [Related]
6. Olfactory deficits in mice overexpressing human wildtype alpha-synuclein.
Fleming SM; Tetreault NA; Mulligan CK; Hutson CB; Masliah E; Chesselet MF
Eur J Neurosci; 2008 Jul; 28(2):247-56. PubMed ID: 18702696
[TBL] [Abstract][Full Text] [Related]
7. Ablation of tau causes an olfactory deficit in a murine model of Parkinson's disease.
Beauchamp LC; Chan J; Hung LW; Padman BS; Vella LJ; Liu XM; Coleman B; Bush AI; Lazarou M; Hill AF; Jacobson L; Barnham KJ
Acta Neuropathol Commun; 2018 Jul; 6(1):57. PubMed ID: 29976255
[TBL] [Abstract][Full Text] [Related]
8. Early fine motor impairment and behavioral dysfunction in (Thy-1)-h[A30P] alpha-synuclein mice.
Ekmark-Lewén S; Lindström V; Gumucio A; Ihse E; Behere A; Kahle PJ; Nordström E; Eriksson M; Erlandsson A; Bergström J; Ingelsson M
Brain Behav; 2018 Mar; 8(3):e00915. PubMed ID: 29541535
[TBL] [Abstract][Full Text] [Related]
9. Olfaction in Parkinson's disease and related disorders.
Doty RL
Neurobiol Dis; 2012 Jun; 46(3):527-52. PubMed ID: 22192366
[TBL] [Abstract][Full Text] [Related]
10. Abrogating Native α-Synuclein Tetramers in Mice Causes a L-DOPA-Responsive Motor Syndrome Closely Resembling Parkinson's Disease.
Nuber S; Rajsombath M; Minakaki G; Winkler J; Müller CP; Ericsson M; Caldarone B; Dettmer U; Selkoe DJ
Neuron; 2018 Oct; 100(1):75-90.e5. PubMed ID: 30308173
[TBL] [Abstract][Full Text] [Related]
11. Deficits in olfactory sensitivity in a mouse model of Parkinson's disease revealed by plethysmography of odor-evoked sniffing.
Johnson ME; Bergkvist L; Mercado G; Stetzik L; Meyerdirk L; Wolfrum E; Madaj Z; Brundin P; Wesson DW
Sci Rep; 2020 Jun; 10(1):9242. PubMed ID: 32514004
[TBL] [Abstract][Full Text] [Related]
12. Application of serum peptidomics for Parkinson's disease in SNCA-A30P mice.
Yin Z; Xu G; Qi Y; Tan DM; Chen EH; Ding X; Ji RY
Heliyon; 2023 Dec; 9(12):e21125. PubMed ID: 38125428
[TBL] [Abstract][Full Text] [Related]
13. Metal concentrations and distributions in the human olfactory bulb in Parkinson's disease.
Gardner B; Dieriks BV; Cameron S; Mendis LHS; Turner C; Faull RLM; Curtis MA
Sci Rep; 2017 Sep; 7(1):10454. PubMed ID: 28874699
[TBL] [Abstract][Full Text] [Related]
14. Spinal cord pathology in alpha-synuclein transgenic mice.
Mendritzki S; Schmidt S; Sczepan T; Zhu XR; Segelcke D; Lübbert H
Parkinsons Dis; 2010 Jul; 2010():375462. PubMed ID: 20976083
[TBL] [Abstract][Full Text] [Related]
15. A novel α-synuclein-GFP mouse model displays progressive motor impairment, olfactory dysfunction and accumulation of α-synuclein-GFP.
Hansen C; Björklund T; Petit GH; Lundblad M; Murmu RP; Brundin P; Li JY
Neurobiol Dis; 2013 Aug; 56():145-55. PubMed ID: 23643841
[TBL] [Abstract][Full Text] [Related]
16. α-Synuclein in the olfactory system of a mouse model of Parkinson's disease: correlation with olfactory projections.
Ubeda-Bañon I; Saiz-Sanchez D; de la Rosa-Prieto C; Martinez-Marcos A
Brain Struct Funct; 2012 Apr; 217(2):447-58. PubMed ID: 21928152
[TBL] [Abstract][Full Text] [Related]
17. α-Synuclein Pathology and Reduced Neurogenesis in the Olfactory System Affect Olfaction in a Mouse Model of Parkinson's Disease.
Martin-Lopez E; Vidyadhara DJ; Liberia T; Meller SJ; Harmon LE; Hsu RM; Spence N; Brennan B; Han K; Yücel B; Chandra SS; Greer CA
J Neurosci; 2023 Feb; 43(6):1051-1071. PubMed ID: 36596700
[TBL] [Abstract][Full Text] [Related]
18. Neurochemical, histological, and behavioral profiling of the acute, sub-acute, and chronic MPTP mouse model of Parkinson's disease.
Santoro M; Fadda P; Klephan KJ; Hull C; Teismann P; Platt B; Riedel G
J Neurochem; 2023 Jan; 164(2):121-142. PubMed ID: 36184945
[TBL] [Abstract][Full Text] [Related]
19. The AKT modulator A-443654 reduces α-synuclein expression and normalizes ER stress and autophagy.
Gandelman M; Dansithong W; Kales SC; Paul S; Maag G; Aoyama E; Zakharov A; Rai G; Dexheimer T; Whitehill BM; Sun H; Jadhav A; Simeonov A; Henderson MJ; Huynh DP; Pulst SM; Scoles DR
J Biol Chem; 2021 Oct; 297(4):101191. PubMed ID: 34520759
[TBL] [Abstract][Full Text] [Related]
20. Animal models of α-synucleinopathy for Parkinson disease drug development.
Koprich JB; Kalia LV; Brotchie JM
Nat Rev Neurosci; 2017 Sep; 18(9):515-529. PubMed ID: 28747776
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
